Has a negative effect on cell proliferation. Interacts with FGF2 with a low affinity. Predominantly localized in the plasma membrane but also detected in the Golgi and in secretory vesicles. Expressed preferentially in cartilaginous tissues and pancreas. Highly expressed in the liver, kidney, heart, brain and skeletal muscle. Weakly expressed in the lung, small intestine and spleen.